Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immuron Presentation Australian Biologics Festival 2024 By: Immuron Limited via GlobeNewswire February 21, 2024 at 06:00 AM EST MELBOURNE, Australia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Research & Development Manager, Joanne Casey, PhD will be presenting at the Australian Biologics Festival 2024 on Wednesday, 21st February in Melbourne, Australia. A copy of the presentation slide deck is available on the Company’s website. https://www.immuron.com.au/corporate-presentations/ Authorised for release by the Board of Immuron Limited. COMPANY CONTACT:Steven LydeamoreChief Executive OfficerPh: +61 (0)3 9824 5254info@immuron.com About ImmuronImmuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. For more information visit: http://www.immuron.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Immuron Presentation Australian Biologics Festival 2024 By: Immuron Limited via GlobeNewswire February 21, 2024 at 06:00 AM EST MELBOURNE, Australia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Research & Development Manager, Joanne Casey, PhD will be presenting at the Australian Biologics Festival 2024 on Wednesday, 21st February in Melbourne, Australia. A copy of the presentation slide deck is available on the Company’s website. https://www.immuron.com.au/corporate-presentations/ Authorised for release by the Board of Immuron Limited. COMPANY CONTACT:Steven LydeamoreChief Executive OfficerPh: +61 (0)3 9824 5254info@immuron.com About ImmuronImmuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. For more information visit: http://www.immuron.com
MELBOURNE, Australia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Research & Development Manager, Joanne Casey, PhD will be presenting at the Australian Biologics Festival 2024 on Wednesday, 21st February in Melbourne, Australia. A copy of the presentation slide deck is available on the Company’s website. https://www.immuron.com.au/corporate-presentations/ Authorised for release by the Board of Immuron Limited. COMPANY CONTACT:Steven LydeamoreChief Executive OfficerPh: +61 (0)3 9824 5254info@immuron.com About ImmuronImmuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. For more information visit: http://www.immuron.com